Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 20, 2018

DrugPatentWatch Database Preview

Hikma Intl Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-three approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms

US Patents:	5
Tradenames:	30
Ingredients:	30
NDAs:	43

Drugs and US Patents for Hikma Intl Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Intl Pharms	MITIGARE	colchicine	CAPSULE;ORAL	204820-001	Sep 26, 2014		RX	Yes	Yes	9,399,036	➤ Sign Up				➤ Sign Up
Hikma Intl Pharms	NAPROXEN	naproxen	TABLET;ORAL	076494-001	Jan 14, 2004		DISCN	No	No		➤ Sign Up				➤ Sign Up
Hikma Intl Pharms	HYDROCORTISONE	hydrocortisone	TABLET;ORAL	083365-001	Approved Prior to Jan 1, 1982	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Hikma Intl Pharms	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	077545-002	Sep 6, 2007		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.6 mg	➤ Subscribe	2016-06-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji

McKesson

Argus Health

Accenture

Deloitte

Express Scripts

Covington

Colorcon

US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.